Pages that link to "Q41906223"
Jump to navigation
Jump to search
The following pages link to Charles-Edouard Luyt (Q41906223):
Displaying 50 items.
- Characteristics of an ideal nebulized antibiotic for the treatment of pneumonia in the intubated patient (Q26752680) (← links)
- Procalcitonin to guide antibiotic therapy in the ICU (Q26775450) (← links)
- French Intensive Care Society, International congress - Réanimation 2016 (Q28550357) (← links)
- Proceedings of Réanimation 2017, the French Intensive Care Society International Congress (Q28564101) (← links)
- Low titers of serum antibodies inhibiting hemagglutination predict fatal fulminant influenza A(H1N1) 2009 infection. (Q30360402) (← links)
- Characterization of pandemic influenza immune memory signature after vaccination or infection. (Q30363416) (← links)
- Antibiotic stewardship in the intensive care unit (Q30408712) (← links)
- Extracorporeal membrane oxygenation for 2009 influenza A (H1N1) acute respiratory distress syndrome: single-centre experience with 1-year follow-up (Q30411488) (← links)
- Impact of extracorporeal membrane oxygenation and continuous venovenous hemodiafiltration on the pharmacokinetics of oseltamivir carboxylate in critically ill patients with pandemic (H1N1) influenza (Q30413369) (← links)
- What is the niche for extracorporeal membrane oxygenation in severe acute respiratory distress syndrome? (Q30420593) (← links)
- Long-term outcomes of pandemic 2009 influenza A(H1N1)-associated severe ARDS. (Q30420961) (← links)
- Serotonin receptor blockade improves distal perfusion after lower limb ischemia in the fatty Zucker rat. (Q33184945) (← links)
- Early High-Volume Hemofiltration versus Standard Care for Post-Cardiac Surgery Shock. The HEROICS Study (Q33424340) (← links)
- Pharmacokinetics and lung delivery of PDDS-aerosolized amikacin (NKTR-061) in intubated and mechanically ventilated patients with nosocomial pneumonia (Q33612643) (← links)
- Pseudomonas aeruginosa serotypes in nosocomial pneumonia: prevalence and clinical outcomes (Q33754176) (← links)
- Recombinant factor VIIa for uncontrollable bleeding in patients with extracorporeal membrane oxygenation: report on 15 cases and literature review (Q33754446) (← links)
- Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial (Q34020982) (← links)
- Procalcitonin to guide initiation and duration of antibiotic treatment in acute respiratory infections: an individual patient data meta-analysis (Q34264291) (← links)
- A randomized double-blind trial of iseganan in prevention of ventilator-associated pneumonia (Q34455145) (← links)
- Prognostic value of procalcitonin in respiratory tract infections across clinical settings (Q35247489) (← links)
- Impact of antibiotic-resistant bacteria on the outcome of ventilator-associated pneumonia (Q36410119) (← links)
- Use of quantitative cultures and reduced duration of antibiotic regimens for patients with ventilator-associated pneumonia to decrease resistance in the intensive care unit (Q36559379) (← links)
- New diagnostic and prognostic markers of ventilator-associated pneumonia (Q36582154) (← links)
- Role of biomarkers in the management of antibiotic therapy: an expert panel review: I - currently available biomarkers for clinical use in acute infections (Q37004095) (← links)
- Role of biomarkers in the management of antibiotic therapy: an expert panel review II: clinical use of biomarkers for initiation or discontinuation of antibiotic therapy (Q37028474) (← links)
- Viral infections in the ICU. (Q37267181) (← links)
- Aerosolized antibiotics to treat ventilator-associated pneumonia (Q37412132) (← links)
- Extracorporeal membrane oxygenation for pheochromocytoma-induced cardiogenic shock (Q37447019) (← links)
- Imipenem, meropenem, or doripenem to treat patients with Pseudomonas aeruginosa ventilator-associated pneumonia (Q37643662) (← links)
- Life-threatening massive pulmonary embolism rescued by venoarterial-extracorporeal membrane oxygenation (Q37724757) (← links)
- Other therapeutic modalities and practices: implications for clinical trials of hospital-acquired or ventilator-associated pneumonia (Q37769544) (← links)
- Diagnostic techniques and procedures for establishing the microbial etiology of ventilator-associated pneumonia for clinical trials: the pros for quantitative cultures (Q37769548) (← links)
- Value of the Serum Procalcitonin Level to Guide Antimicrobial Therapy for Patients with Ventilator-Associated Pneumonia (Q37867057) (← links)
- Out-of-hospital extra-corporeal life support implantation during refractory cardiac arrest in a half-marathon runner (Q37871170) (← links)
- Biomarkers to optimize antibiotic therapy for pneumonia due to multidrug-resistant pathogens (Q37922284) (← links)
- Delivering antibiotics to the lungs of patients with ventilator-associated pneumonia: an update (Q38102781) (← links)
- White matter changes in comatose survivors of anoxic ischemic encephalopathy and traumatic brain injury: comparative diffusion-tensor imaging study (Q38182635) (← links)
- What role do viruses play in nosocomial pneumonia? (Q38184882) (← links)
- Could the DiversiLab® semi-automated repetitive-sequence-based PCR be an acceptable technique for typing isolates of Pseudomonas aeruginosa? An answer from our experience and a review of the literature (Q38605820) (← links)
- The Clinical Picture of Severe Systemic Capillary-Leak Syndrome Episodes Requiring ICU Admission (Q38670151) (← links)
- Brain injury during venovenous extracorporeal membrane oxygenation (Q38785984) (← links)
- Extracorporeal Membrane Oxygenation for Acute Decompensated Heart Failure (Q38804699) (← links)
- Can we improve clinical outcomes in patients with pneumonia treated with antibiotics in the intensive care unit? (Q38835029) (← links)
- Extracorporeal membrane oxygenation: beyond rescue therapy for acute respiratory distress syndrome? (Q39016735) (← links)
- Venoarterial extracorporeal membrane oxygenation for refractory cardiogenic shock post-cardiac arrest (Q39342710) (← links)
- The PRESERVE mortality risk score and analysis of long-term outcomes after extracorporeal membrane oxygenation for severe acute respiratory distress syndrome (Q39373938) (← links)
- Predictors of successful extracorporeal membrane oxygenation (ECMO) weaning after assistance for refractory cardiogenic shock (Q39701817) (← links)
- Pharmacodynamics of carbapenems for the treatment of Pseudomonas aeruginosa ventilator-associated pneumonia: associations with clinical outcome and recurrence (Q39702978) (← links)
- The ENCOURAGE mortality risk score and analysis of long-term outcomes after VA-ECMO for acute myocardial infarction with cardiogenic shock (Q40042007) (← links)
- New Strategies Targeting Virulence Factors of Staphylococcus aureus and Pseudomonas aeruginosa (Q40186210) (← links)